:

Masahide Isowa1, Reo Hamaguchi1, Ryoko Narui1

  • 1Japanese Society on Inflammation and Metabolism in Cancer, Nakagyo-ku, Kyoto, Japan.

Frontiers in oncology
|June 14, 2023
PubMed
概括

与标准治疗相结合的化疗法可能会改善肝细胞癌 (HCC) 患者的治疗结果. 保持尿液pH值为7.0或更高与HCC患者的整体存活时间显著延长有关.